Todd Davis, CEO, Director at Ligand Pharma, holds 123.01K shares in Ligand Pharma (Ticker: LGND), holds 29.17K shares in Chromocell Therapeutics Corp (Ticker: CHRO), holds 125.91K shares in Vaxart (Ticker: VXRT). Most recently, Todd Davis Bought ― shares of Ligand Pharma on Aug 09, 2024 for an estimated value of 243.47K.
What is the percentage of profitable transactions made by Todd Davis?
The percentage of profitable transactions made by Todd Davis is 91%.
What is the average return per transaction made by Todd Davis?
The average return per transaction made by Todd Davis is 0.50%.
What stocks does Todd Davis hold?
Todd Davis holds: LGND, BDSI, VXRT, CHRO stocks.
What was Todd Davis’s latest transaction?
Todd Davis latest transaction was an Informative Buy of $243.47K.
What was Todd Davis's most profitable transaction?
Todd Davis’s most profitable transaction was an Informative Buy of LGND stock on September 25, 2023. The return on the trade was 77.90%.
What is Todd Davis's role in Ligand Pharma?
Todd Davis's role in Ligand Pharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.